Literature DB >> 22223241

Baroreflex sensitivity to predict malignant middle cerebral artery infarction.

Marek Sykora1, Thorsten Steiner, Andrea Rocco, Peter Turcani, Werner Hacke, Jennifer Diedler.   

Abstract

BACKGROUND AND
PURPOSE: Hemicraniectomy has been shown to be an effective treatment of life-threatening edema (LTE) in malignant middle cerebral artery infarction when performed early. Identifying patients who will develop LTE is therefore imperative. We hypothesize that autonomic shift toward sympathetic dominance may relate to LTE formation. We aimed to investigate the predictive potential of baroreflex sensitivity (BRS) as a marker of autonomic balance for calculating the course of large middle cerebral artery infarction.
METHODS: Patients with middle cerebral artery infarction >2/3 of the territory and BRS measurement at admission were analyzed. BRS was estimated using the cross-correlational method. Demographic, clinical, and radiological data including stroke severity, infarct size, and basal ganglia involvement were recorded. Malignant course with LTE was defined as clinical deterioration and midline shift ≥5 mm in the first 48 hours.
RESULTS: Eighteen (62.8%) patients developed LTE. Patients with LTE had lower BRS (2.3 versus 4.4 mm Hg/ms, P=0.007), larger infarcts (214 versus 144 mL, P=0.03), more frequent involvement of the basal ganglia (14 versus 4, P=0.03), and more often underwent thrombolysis combined with endovascular intervention (6 versus 0, P=0.04). In a multivariate model, BRS (OR, 0.36; CI, 0.14-0.93; P=0.03) and basal ganglia involvement (OR, 11.53; CI, 1.15-115.9; P=0.04) were independent predictors for LTE. This model correctly classified 86.2% of the malignant cases.
CONCLUSIONS: Decreased BRS, mirroring sympathetic activation, and basal ganglia involvement were associated with development of malignant course with LTE in large middle cerebral artery infarction. The predictive relevance of our findings needs to be confirmed in further studies.

Entities:  

Mesh:

Year:  2012        PMID: 22223241     DOI: 10.1161/STROKEAHA.111.632778

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Assessment of Autonomic Dysfunction in Acute Stroke Patients at a Tertiary Care Hospital.

Authors:  Hemachandrika Chidambaram; Kothai Gnanamoorthy; Prasanna Karthik Suthakaran; Kannan Rajendran; Chitrambalam Pavadai
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 2.  Malignant MCA Stroke: an Update on Surgical Decompression and Future Directions.

Authors:  Carolina B Maciel; Kevin N Sheth
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

3.  Imaging Findings Associated with Space-Occupying Edema in Patients with Large Middle Cerebral Artery Infarcts.

Authors:  A D Horsch; J W Dankbaar; T A Stemerdink; E Bennink; T van Seeters; L J Kappelle; J Hofmeijer; H W de Jong; Y van der Graaf; B K Velthuis
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-21       Impact factor: 3.825

4.  Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction.

Authors:  Frans Kauw; Edwin Bennink; Hugo W A M de Jong; L Jaap Kappelle; Alexander D Horsch; Birgitta K Velthuis; Jan W Dankbaar
Journal:  Stroke       Date:  2019-05-16       Impact factor: 7.914

5.  Cardiomyocyte Injury Following Acute Ischemic Stroke: Protocol for a Prospective Observational Cohort Study.

Authors:  Helena Stengl; Ramanan Ganeshan; Simon Hellwig; Edyta Blaszczyk; Jochen B Fiebach; Christian H Nolte; Axel Bauer; Jeanette Schulz-Menger; Matthias Endres; Jan F Scheitz
Journal:  JMIR Res Protoc       Date:  2021-02-05

6.  Effect of Cerebral Ischemic Strokes in Different Cerebral Artery Regions on Left Ventricular Function.

Authors:  Li-Juan Zheng; Xin Lin; Yun-Jing Xue
Journal:  Front Cardiovasc Med       Date:  2022-03-08

7.  Valsalva maneuver unveils central baroreflex dysfunction with altered blood pressure control in persons with a history of mild traumatic brain injury.

Authors:  Max J Hilz; Mao Liu; Julia Koehn; Ruihao Wang; Fabian Ammon; Steven R Flanagan; Katharina M Hösl
Journal:  BMC Neurol       Date:  2016-05-04       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.